Novo Nordisk

 

NOTE: IAPO is in no way responsible for the content of the Industry Partner profiles.  These have been produced using information provided by the Industry Partners.

Novo Nordisk is a global healthcare company with 88 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.

Headquartered in Denmark, Novo Nordisk employs approximately 31,400 employees in 74 countries, and markets its products in 179 countries.

www.novonordisk.com